# CervoMed (CRVO) — News

CRVO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/crvo/news

## Recent headlines

- [Cervomed - Neflamapimod generally well tolerated with no new safety signals identified](https://www.ainvest.com/news/cervomed-neflamapimod-generally-tolerated-safety-signals-identified-2610) — AInvest Wire, Oct 12, 2026
  CervoMed recently reported that neflamapimod, its investigational drug, has demonstrated a favorable safety profile in ongoing trials, with no new safety signals identified. The compound, currently under evaluation for potential use in dementia-related conditions, has shown general tolerability…
- [Cervomed Q2 net income USD -6.6 million vs. IBES estimate USD -8.56 million](https://www.ainvest.com/news/cervomed-q2-net-income-usd-6-6-million-ibes-estimate-usd-8-56-million-2608) — AInvest Wire, Aug 10, 2026
- [Canaccord Genuity cuts target price to $18 from $27 for Cervomed Inc](https://www.ainvest.com/news/canaccord-genuity-cuts-target-price-18-27-cervomed-2608) — AInvest Wire, Aug 10, 2026
  Canaccord Genuity has revised its price target for CervoMed Inc. (NASDAQ: CRVO), lowering it to $18 from $27, while maintaining a Buy rating for the biopharmaceutical company. The adjustment reflects updated assumptions regarding the regulatory and commercial trajectory of CervoMed’s lead…
- [Cervomed - files to register resale of 10.08 mln shares of common stock - SEC filing](https://www.ainvest.com/news/cervomed-files-register-resale-10-08-mln-shares-common-stock-sec-filing-2607) — AInvest Wire, Jul 6, 2026
- [Cervomed announces closing of $10 million registered direct offering of common stock priced at-the-market under Nasdaq rules](https://www.ainvest.com/news/cervomed-announces-closing-10-million-registered-direct-offering-common-stock-priced-market-nasdaq-rules-2606) — AInvest Wire, Jun 22, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).